What You Should Know:
- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific region) for lerociclib for all indications outside acute radiation syndrome (ARS).
- As Pepper Bio’s first in-licensed therapeutic, lerociclib is a potent and selective
Read More
Kaiser Permanente to Deploy Innovaccer’s Healthcare AI Platform
What You Should Know:
- Innovaccer, a leading healthcare technology company, today announced its collaboration with Kaiser Permanente, America’s leading healthcare provider and nonprofit health plan.
- Kaiser Permanente will implement Innovaccer’s Healthcare AI Platform to support value-based care initiatives.
Empowering
Read More
Vitestro Secures $22M for Autonomous Blood Draw Device
What You Should Know:
- Vitestro, the pioneering autonomous blood drawing company, today announced that it has raised $22 million (€20 million) funding to accelerate commercialization of its innovative robotic blood drawing device.
- This brings its total funding raised to $50 million (€46 million) from both equity investments and grant funding.
Vitestro Secures Oversubscribed Funding Round to Drive European
Read More
Guidehealth & PA Clinical Network Partners with to Help Independent Providers Succeed in VBC
What You Should Know:
- PA Clinical Network (PACN), the nation’s only state medical society, physician-led clinically integrated network and Guidehealth, a nationally acclaimed, AI-enabled healthcare services provider, today announced a multi-year strategic partnership to improve healthcare for Pennsylvania patients.
- Leveraging the Guidehealth platform and patient care management guides, the collaboration will allow
Read More
WebMD Ignite Unveils HealthHub Interactive to Support Health Plans’ Clinical Programs
What You Should Know:
- WebMD Ignite, a full-service growth partner for organizations across the healthcare industry, today announced HealthHub Interactive for health plans, a suite of new technology-driven solutions specifically designed to power health plan clinical programs.
- HealthHub Interactive bundles three proven WebMD Ignite
Read More
Telehealth Nutrition Program Proves Effective in Fighting Food Insecurity
What You Should Know:
- Foodsmart, the leader in telenutrition and food benefits management, today announced the results of a new study stemming from its partnership of almost 3 years with Chorus Community Health Plans (CCHP), an affiliate of Children’s Wisconsin.
- In an effort to bridge the nutrition access gap in Wisconsin and
Read More
Philips Receives FDA 510(k) Clearance on Image-Guided Surgical Therapy
What You Should Know:
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its Philips Zenition 30 mobile C-arm has received FDA 510(k) clearance, making image-guided surgical procedures available to more US patients at lower cost.
- By giving surgeons greater flexibility, control, and
Read More
Brigham and Women’s Hospital Uncovers $4.8M in Potential Savings, Announces New AI Study + Integration
What You Should Know:
- FeelBetter, the leading provider of polypharmacy patient management technology and pioneer of Pharmaco-Clinical Intelligence, today announced a collaboration on a prospective research study with investigators at Brigham and Women’s Hospital in Boston.
- The research will assess the impact of FeelBetter’s AI-based
Read More
Humana Expands Use of Cohere Health’s Prior Authorization Platform
What You Should Know:
- Cohere Health, a recognized leader in clinical intelligence and prior authorization automation, announced that Humana Inc. (NYSE: HUM) will expand its use of Cohere's prior authorization platform for diagnostic imaging and sleep services.
- In January 2021, Cohere and Humana began a pilot
Read More
Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure
What You Should Know:
Exo® (pronounced “echo”), a medical imaging software and devices company, today announced its FDA-cleared cardiac and lung artificial intelligence (AI) applications are now available on Exo Iris™, Exo’s high-performance handheld ultrasound device. With affordable, AI-powered medical imaging in a pocket-sized device, caregivers can get to answers immediately to accelerate diagnosis and create new care pathways for heart failure patients at the point of care. As
Read More
